Rigel Pharmaceuticals regains rights as Lilly terminates license deal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/29/2026

1. V
2. PYPL
3. KLAC
4. SPY
5. F
6. STX
7. CSGP
8. BE
9. SWKS
10. MSFT

Go back to Rigel Pharmaceuticals regains rights as Lilly terminates license deal
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1210.02 -10.64 (0.87%)
Previous Close $1220.66    52 Week High $88.16 
Open $1215.18    52 Week Low $67.88 
Day High $1229.19    P/E 280.10 
Day Low $1204.80    EPS $4.32 
Volume 2,167,505       

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) Delayed: 39.07 +0.57 (1.48%)
Previous Close $38.50    52 Week High $4.38 
Open $38.58    52 Week Low $1.88 
Day High $39.95    P/E N/A 
Day Low $37.95    EPS $-1.12 
Volume 223,387